Why MS Patients Should NOT Take Gilenya
Eleven multiple sclerosis patients are reported to have died after taking the multiple sclerosis (MS) drug Gilenya. A relative newcomer to the market, Gilenya is the first oral drug that has been approved by the U.S. Food and Drug Administration (FDA) to reduce relapses and delay disability in patients who have relapsing forms of MS. [...]

